Patents by Inventor William Carlezon

William Carlezon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Salvinorin derivatives and uses thereof
    Patent number: 8492564
    Abstract: The invention features salvinorin compositions that are selective for kappa opioid receptors; methods of treating mania by using a selective kappa receptor agonist; and methods of treating mood disorders, such as depressive disorders and manic disorders, using salvinorin compositions.
    Type: Grant
    Filed: December 14, 2009
    Date of Patent: July 23, 2013
    Assignees: The McLean Hospital Corporation, Temple University School of Medicine
    Inventors: Cecile Beguin, Justin Stephen Potuzak, Thomas Anthony Munro, Katharine K. Duncan, William A. Carlezon, Bruce M. Cohen, Lee-yuan Liu-Chen
  • SALVINORIN DERIVATIVES AND USES THEREOF
    Publication number: 20120010219
    Abstract: The invention features salvinorin compositions that are selective for kappa opioid receptors; methods of treating mania by using a selective kappa receptor agonist; and methods of treating mood disorders, such as depressive disorders and manic disorders, using salvinorin compositions.
    Type: Application
    Filed: December 14, 2009
    Publication date: January 12, 2012
    Applicant: The McLean Hospital Corporation
    Inventors: Cecile Beguin, Justin Stephen Potuzak, Thomas Anthony Munro, Katherine K. Duncan, William A. Carlezon, Bruce M. Cohen, Lee-yuan Liu Chen
  • Salvinorin Derivatives and Uses Thereof
    Publication number: 20100324131
    Abstract: The invention features salvinorin compositions that are selective for kappa opioid receptors; methods of treating mania by using a selective kappa receptor agonist; and methods of treating mood disorders, such as depressive disorders and manic disorders, using salvinorin compositions.
    Type: Application
    Filed: August 6, 2010
    Publication date: December 23, 2010
    Inventors: Cécile Béguin, William A. Carlezon, Bruce M. Cohen, Minsheng He, David Yue-Wei Lee, Michele R. Richards, Lee-Yuan Liu Chen
  • METHODS OF TREATING PSYCHIATRIC, SUBSTANCE ABUSE, AND OTHER DISORDERS USING COMBINATIONS CONTAINING OMEGA-3 FATTY ACIDS
    Publication number: 20100197628
    Abstract: The invention provides methods for treating or preventing psychiatric disorders, substance abuse disorders, and other conditions, e.g., cardiovascular disease and cancer, involving administration of a therapeutically-effective amount of a cytosine-containing or cytidine-containing compound, creatine-containing compound, adenosine-containing, adenosine-elevating compound, omega-3 fatty acids, or combinations thereof to a mammal. The invention further provides methods of enhancing neurodevelopment and delaying premature pregnancy by administration of an effective amount of a cytosine-containing or cytidine-containing compound, creatine-containing compound, adenosine-containing, adenosine-elevating compound, omega-3 fatty acids, or combinations thereof to a mammal.
    Type: Application
    Filed: February 12, 2010
    Publication date: August 5, 2010
    Inventors: Perry F. Renshaw, William A. Carlezon, JR., Bruce M. Cohen
  • Salvinorin derivatives and uses thereof
    Patent number: 7629475
    Abstract: The invention features salvinorin compositions that are selective for kappa opioid receptors; methods of treating mania by using a selective kappa receptor agonist; and methods of treating mood disorders, such as depressive disorders and manic disorders, using salvinorin compositions.
    Type: Grant
    Filed: March 14, 2005
    Date of Patent: December 8, 2009
    Assignee: The McLean Hospital Corporation
    Inventors: Cécile Béquin, William A. Carlezon, Bruce M. Cohen, Minsheng He, David Yue-Wei Lee, Michele R. Richards, Lee-Yuan Liu-Chen
  • Treatment and screening methods for promoting neurogenesis
    Publication number: 20070259831
    Abstract: The invention features methods for promoting neurogenesis including treatment of psychiatric disorders (e.g., depression, bipolar disorder, and post traumatic stress disorder), drug abuse or addiction, neurodegenerative diseases (e.g., Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, frontotemporal dementia, Huntington's disease, and prion disease), and head trauma (e.g., stroke and physical injury) by inhibition of Sprouty (SPRY) and methods for identification of compounds useful promoting neurogenesis (e.g., useful in the treatment of psychiatric disorders, drug abuse or addiction, neurodegenerative diseases, or head trauma).
    Type: Application
    Filed: April 27, 2007
    Publication date: November 8, 2007
    Inventor: William Carlezon
  • Salvinorin derivatives and uses thereof
    Publication number: 20070213394
    Abstract: The invention features salvinorin compositions that are selective for kappa opioid receptors; methods of treating mania by using a selective kappa receptor agonist; and methods of treating mood disorders, such as depressive disorders and manic disorders, using salvinorin compositions.
    Type: Application
    Filed: September 29, 2006
    Publication date: September 13, 2007
    Inventors: Cecile Beguin, William Carlezon, Bruce Cohen, Minsheng He, David Lee, Michele Richards, Lee-Yuan Liu-Chen
  • Salvinorin derivatives and uses thereof
    Publication number: 20060052439
    Abstract: The invention features salvinorin compositions that are selective for kappa opioid receptors; methods of treating mania by using a selective kappa receptor agonist; and methods of treating mood disorders, such as depressive disorders and manic disorders, using salvinorin compositions.
    Type: Application
    Filed: March 14, 2005
    Publication date: March 9, 2006
    Inventors: Cecile Beguin, William Carlezon, Bruce Cohen, Minsheng He, David Lee, Michele Richards, Lee-Yuan Liu-Chen
  • Methods of treating psychiatric substance abuse, and other disorders using combinations containing omega-3 fatty acids
    Publication number: 20050129710
    Abstract: The invention provides methods for treating or preventing psychiatric disorders, substance abuse disorders, and other conditions, e.g., cardiovascular disease and cancer, involving administration of a therapeutically-effective amount of a cytosine-containing or cytidine-containing compound, creatine-containing compound, adenosine-containing, adenosine-elevating compound, omega-3 fatty acids, or combinations thereof to a mammal. The invention further provides methods of enhancing neurodevelopment and delaying premature pregnancy by administration of an effective amount of a cytosine-containing or cytidine-containing compound, creatine-containing compound, adenosine-containing, adenosine-elevating compound, omega-3 fatty acids, or combinations thereof to a mammal.
    Type: Application
    Filed: October 8, 2004
    Publication date: June 16, 2005
    Inventors: Perry Renshaw, William Carlezon, Bruce Cohen
  • Treatment of depression with kappa receptor antagonists
    Patent number: 6528518
    Abstract: The invention features the treatment of depression using kappa opioid receptor antagonists.
    Type: Grant
    Filed: December 20, 2001
    Date of Patent: March 4, 2003
    Assignee: The McLean Hospital Corporation
    Inventor: William A. Carlezon, Jr.